Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase III AIRTIVITY study design: verducatib (BI 1291583) in people with bronchiectasis. | ERJ Open Res | 2026 | 42820152 | PubTator, text mining | PubMed |
| Sputum cathepsin G activity predicts exacerbations and hospitalisations in bronchiectasis. | ERJ Open Res | 2026 | 42807352 | PubTator, text mining | PubMed |
| Brensocatib in non-cystic fibrosis bronchiectasis: neutrophil serine protease modulation, clinical evidence, and therapeutic positioning. | Expert Rev Clin Pharmacol | 2026 | 42788768 | PubTator, text mining | PubMed |
| Medical issues and pulmonary outcomes in cystic fibrosis and bronchiectasis. | Curr Opin Pulm Med | 2026 | 42755280 | PubTator, text mining | PubMed |
| Composition and Function of Decellularized Human Lung Extracellular Matrix from Congenital Pulmonary Airway Malformation. | J Clin Med | 2026 | 42739747 | PubTator, text mining | PubMed |
| Machine learning-assisted plasma PEA proteomics enables differential diagnosis of melancholic depression and bipolar disorder. | J Affect Disord | 2026 | 42716347 | PubTator, text mining | PubMed |
| Population Pharmacokinetic Analysis of Brensocatib in Adult and Adolescent Patients With Non-Cystic Fibrosis Bronchiectasis. | CPT Pharmacometrics Syst Pharmacol | 2026 | 42712175 | PubTator, text mining | PubMed |
| Multi-omics Mendelian Randomization Prioritizes Neutrophil Extracellular Trap-related Genes Associated with Atrial Fibrillation Risk. | Endocr Metab Immune Disord Drug Targets | 2026 | 42693724 | PubTator, text mining | PubMed |
| Florensocatib in adults with bronchiectasis: the HOPE-BE trial protocol and baseline demographic characteristics. | ERJ Open Res | 2026 | 42639008 | PubTator, text mining | PubMed |
| Impact of KCl-divalent salt synergistic substitution on protease activity and volatile flavor profile in sodium-reduced sour meat. | Food Chem X | 2026 | 42620897 | PubTator, text mining | PubMed |
| Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output. | Cold Spring Harb Perspect Biol | 2026 | 42575696 | PubTator, text mining | PubMed |
| Case Report: Papillon-Lefèvre syndrome beyond keratoderma: two index presentations and sibling screening in two families. | Front Immunol | 2026 | 42568397 | PubTator, text mining | PubMed |
| Efficacy and Safety of Brensocatib in Participants of Asian Race with Non-cystic Fibrosis Bronchiectasis: A Subgroup Analysis of the ASPEN Trial. | Pulm Ther | 2026 | 42461571 | PubTator, text mining | PubMed |
| Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition. | Ann Med Surg (Lond) | 2026 | 42433850 | PubTator, text mining | PubMed |
| Decoding cardiotoxicity through proteomics and metabolomics: cathepsin C and amino acids take centre stage. | Eur Heart J | 2026 | 42424033 | PubTator, text mining | PubMed |
| The Potential Role of DPP-1 Inhibitors in Chronic Obstructive Pulmonary Disease. | Arch Bronconeumol | 2026 | 42414195 | PubTator, text mining | PubMed |
| Targeting the neutrophil-DPP-1-protease axis in airway disease: current evidence and future indications. | Respir Med | 2026 | 42372954 | PubTator, text mining | PubMed |
| Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling. | Eur Heart J | 2026 | 42366805 | PubTator, text mining | PubMed |
| Honeycomb-pattern of plantar keratoderma in a patient with biallelic CTSC pathogenic variants. | J Dtsch Dermatol Ges | 2026 | 42366561 | PubTator, text mining | PubMed |
| Long-term periodontal maintenance in a patient with Papillon-Lefèvre syndrome: an 8-year case report. | BMC Oral Health | 2026 | 42363159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers